These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22429494)

  • 1. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma.
    Hai C; Jin YM; Jin WB; Han ZZ; Cui MN; Piao XZ; Shen XH; Zhang SN; Sun HH
    Chin J Cancer; 2012 May; 31(5):233-40. PubMed ID: 22429494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.
    Zhang J; Chen H; Chen C; Liu H; He Y; Zhao J; Yang P; Mao Q; Xia H
    Cancer Lett; 2021 Jul; 509():26-38. PubMed ID: 33819529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
    Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
    Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
    Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
    Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
    Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
    Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic mesenchymal stem cells loaded with telomerase-dependent oncolytic adenoviruses enhance anti-metastatic efficacy.
    Yang ML; Hu CY; Lee YC; Chang CC; Chen YC; Lee PR; Su BH; Chen PC; Shiau AL; Shieh GS; Wu CL; Wu P
    Stem Cells Transl Med; 2024 Aug; 13(8):738-749. PubMed ID: 38864209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.
    Hakkarainen T; Särkioja M; Lehenkari P; Miettinen S; Ylikomi T; Suuronen R; Desmond RA; Kanerva A; Hemminki A
    Hum Gene Ther; 2007 Jul; 18(7):627-41. PubMed ID: 17604566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
    Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
    Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
    Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
    Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.
    Jiang H; Gomez-Manzano C; Lang FF; Alemany R; Fueyo J
    Curr Gene Ther; 2009 Oct; 9(5):422-7. PubMed ID: 19860656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model.
    Mao J; Cao M; Zhang F; Zhang J; Duan X; Lu L; Yang Z; Zhang X; Zhu W; Zhang Q; Wang Z; Shen J
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
    Chastkofsky MI; Pituch KC; Katagi H; Zannikou M; Ilut L; Xiao T; Han Y; Sonabend AM; Curiel DT; Bonner ER; Nazarian J; Horbinski CM; James CD; Saratsis AM; Hashizume R; Lesniak MS; Balyasnikova IV
    Clin Cancer Res; 2021 Mar; 27(6):1766-1777. PubMed ID: 33272983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.
    Lee HK; Finniss S; Cazacu S; Bucris E; Ziv-Av A; Xiang C; Bobbitt K; Rempel SA; Hasselbach L; Mikkelsen T; Slavin S; Brodie C
    Oncotarget; 2013 Feb; 4(2):346-61. PubMed ID: 23548312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma.
    Kim JW; Kane JR; Young JS; Chang AL; Kanojia D; Morshed RA; Miska J; Ahmed AU; Balyasnikova IV; Han Y; Zhang L; Curiel DT; Lesniak MS
    Hum Gene Ther; 2015 Sep; 26(9):635-46. PubMed ID: 26058317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
    Yong RL; Shinojima N; Fueyo J; Gumin J; Vecil GG; Marini FC; Bogler O; Andreeff M; Lang FF
    Cancer Res; 2009 Dec; 69(23):8932-40. PubMed ID: 19920199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
    Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
    Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.